DaVita Inc
DVA111.450USD
-1.140-1.01%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
7.91BMarket Cap
11.23P/E TTM
More Details of DaVita Inc Company
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
DaVita Inc Info
Ticker SymbolDVA
Company nameDaVita Inc
IPO dateOct 31, 1995
CEORodriguez (Javier J)
Number of employees76000
Security typeOrdinary Share
Fiscal year-endOct 31
Address2000 16th St
CityDENVER
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code80202-5117
Phone13105362668
Websitehttps://www.davita.com/
Ticker SymbolDVA
IPO dateOct 31, 1995
CEORodriguez (Javier J)
Company Executives of DaVita Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
832.67K
-5165.00%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8191.00%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+7388.00%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.36K
+411.00%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+3834.00%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
14.54K
+260.00%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
13.98K
+411.00%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
13.44K
+411.00%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
13.08K
-7501.00%
Dr. Gregory J. Moore, M.D., Ph.D.
Dr. Gregory J. Moore, M.D., Ph.D.
Independent Director
Independent Director
7.23K
+411.00%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
832.67K
-5165.00%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8191.00%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+7388.00%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.36K
+411.00%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+3834.00%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
14.54K
+260.00%
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Patient service - Medicare and Medicare Advantage
1.72B
50.15%
Patient service - Commercial
1.06B
30.86%
Patient service - Other government
324.62M
9.49%
Patient service - Medicaid and Managed Medicaid
214.66M
6.28%
Other - Medicare and Medicare Advantage
85.88M
2.51%
Other
24.33M
0.71%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Patient service - Medicare and Medicare Advantage
1.72B
50.15%
Patient service - Commercial
1.06B
30.86%
Patient service - Other government
324.62M
9.49%
Patient service - Medicaid and Managed Medicaid
214.66M
6.28%
Other - Medicare and Medicare Advantage
85.88M
2.51%
Other
24.33M
0.71%
Shareholding Stats
Updated: Thu, Dec 4
Updated: Thu, Dec 4
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Berkshire Hathaway Inc.
44.98%
The Vanguard Group, Inc.
5.96%
BlackRock Institutional Trust Company, N.A.
3.39%
Weschler (R Ted)
3.09%
State Street Investment Management (US)
2.60%
Other
39.97%
Shareholders
Shareholders
Proportion
Berkshire Hathaway Inc.
44.98%
The Vanguard Group, Inc.
5.96%
BlackRock Institutional Trust Company, N.A.
3.39%
Weschler (R Ted)
3.09%
State Street Investment Management (US)
2.60%
Other
39.97%
Shareholder Types
Shareholders
Proportion
Holding Company
44.99%
Investment Advisor
25.80%
Investment Advisor/Hedge Fund
14.44%
Hedge Fund
5.47%
Individual Investor
5.06%
Research Firm
2.42%
Pension Fund
2.16%
Bank and Trust
0.87%
Sovereign Wealth Fund
0.35%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
1272
36.41M
51.56%
-4.55M
2025Q3
1299
36.28M
57.59%
-1.47M
2025Q2
1288
37.75M
54.27%
+725.11K
2025Q1
1275
37.24M
54.43%
-4.83M
2024Q4
1234
39.31M
53.45%
-1.10M
2024Q3
1192
40.91M
54.63%
-1.68M
2024Q2
1162
42.62M
55.55%
-1.85M
2024Q1
1146
44.41M
55.70%
-4.44M
2023Q4
1143
45.66M
55.03%
+259.36K
2023Q3
1139
46.32M
54.25%
+1.22M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Berkshire Hathaway Inc.
31.76M
44.98%
-401.51K
-1.25%
Oct 27, 2025
The Vanguard Group, Inc.
4.21M
5.96%
-518.53K
-10.97%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.40M
3.39%
-242.29K
-9.18%
Sep 30, 2025
Weschler (R Ted)
2.18M
3.09%
--
--
Aug 06, 2024
State Street Investment Management (US)
1.83M
2.6%
-258.50K
-12.35%
Sep 30, 2025
Invesco Capital Management LLC
1.40M
1.98%
+57.02K
+4.25%
Sep 30, 2025
Gates Capital Management, Inc.
1.19M
1.69%
+91.40K
+8.32%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.09M
1.54%
+88.06K
+8.83%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.02M
1.45%
-86.31K
-7.78%
Sep 30, 2025
LSV Asset Management
927.03K
1.31%
-13.70K
-1.46%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Aztlan Global Stock Selection DM SMID ETF
2.59%
State Street SPDR S&P Health Care Services ETF
1.84%
Strategas Global Policy Opportunities ETF
1.64%
Invesco S&P 500 Equal Weight Health Care ETF
1.47%
Pacer US Cash Cows Growth ETF
1.02%
AdvisorShares Insider Advantage ETF
0.95%
Global X Aging Population ETF
0.75%
iShares U.S. Healthcare Providers ETF
0.67%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.67%
LeaderShares AlphaFactor US Core ETF
0.66%
View more
Aztlan Global Stock Selection DM SMID ETF
Proportion2.59%
State Street SPDR S&P Health Care Services ETF
Proportion1.84%
Strategas Global Policy Opportunities ETF
Proportion1.64%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.47%
Pacer US Cash Cows Growth ETF
Proportion1.02%
AdvisorShares Insider Advantage ETF
Proportion0.95%
Global X Aging Population ETF
Proportion0.75%
iShares U.S. Healthcare Providers ETF
Proportion0.67%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Proportion0.67%
LeaderShares AlphaFactor US Core ETF
Proportion0.66%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of DaVita Inc?
The top five shareholders of DaVita Inc are:
Berkshire Hathaway Inc. holds 31.76M shares, accounting for 44.98% of the total shares.
The Vanguard Group, Inc. holds 4.21M shares, accounting for 5.96% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.40M shares, accounting for 3.39% of the total shares.
Weschler (R Ted) holds 2.18M shares, accounting for 3.09% of the total shares.
State Street Investment Management (US) holds 1.83M shares, accounting for 2.60% of the total shares.
Berkshire Hathaway Inc. holds 31.76M shares, accounting for 44.98% of the total shares.
The Vanguard Group, Inc. holds 4.21M shares, accounting for 5.96% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.40M shares, accounting for 3.39% of the total shares.
Weschler (R Ted) holds 2.18M shares, accounting for 3.09% of the total shares.
State Street Investment Management (US) holds 1.83M shares, accounting for 2.60% of the total shares.
What are the top three shareholder types of DaVita Inc?
The top three shareholder types of DaVita Inc are:
Berkshire Hathaway Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Berkshire Hathaway Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of DaVita Inc (DVA)?
As of 2025Q4, 1272 institutions hold shares of DaVita Inc, with a combined market value of approximately 36.41M, accounting for 51.56% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -6.02%.
What is the biggest source of revenue for DaVita Inc?
In FY2025Q3, the Patient service - Medicare and Medicare Advantage business generated the highest revenue for DaVita Inc, amounting to 1.72B and accounting for 50.15% of total revenue.
